Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 16
  • Journal CiteScore: 5.60
  • Journal Impact Factor: 4.86
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page


Polymyalgia Rheumatica and Asthma Attack Presenting as the Initial Symptoms of Gastric Cancer

Yang Liu, Yan Hua, Wang Bing, Zhou Henghua and Guo Mei

Gastric cancer has varied clinical manifestations, sometimes the symptoms seem to be nothing related to the gastrointestinal diseases, which makes it difficult for doctors to come to the correct diagnosis of gastric cancer in those patients. We report a case of polymyalgia Rheumatica and intermittent asthma attack presenting as the initial symptoms of gastric cancer. A 51-year-old female visited our hospital with complaint of multi-point pain of her body for three months, accompanied with asthma-like attack and abdominal mass for 2 weeks. All the results of rheumatoid factor and antinuclear factor were negative. She didn't get any benefit from the treatment of prednisone, MTX and folic acid. Then upper gastrointestinal(GI) endoscopy demonstrated a gastric cancer. The patient underwent radical gastrectomy with D2 lymph node dissection and complex of intestinal adhesion release, her polymyalgia Rheumatica and asthma-like attack were relieved 1 week later, she gained weight and received chemotherapy. Followed up 6 years by for now, she was found going well without any evidence of recurrence of cancer or any episode of flareup of polymyalgia Rheumatica or asthma. This indicates that when doctors met patients whose clinical manifestations were shown as refractory ones, the underlying cancer should be under consideration.